Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1989 Dec;210(6):725–731. doi: 10.1097/00000658-198912000-00006

Long-term injection sclerotherapy treatment for esophageal varices. A 10-year prospective evaluation.

J Terblanche 1, D Kahn 1, P C Bornman 1
PMCID: PMC1357863  PMID: 2589885

Abstract

Long-term injection sclerotherapy after proved variceal bleeding was assessed in 245 patients. The majority had alcoholic cirrhosis and the patients were equally distributed between modified Pugh-Child's risk grades A, B, and C. Esophageal varices were eradicated in 88% of the 140 patients who survived long enough for analysis, and remained eradicated for a mean of 19.4 months. The incidence of recurrent variceal bleeding after the first hospital admission was 0.02 bleeding episodes per patient month of follow-up study and was markedly reduced after eradication of varices. The overall cumulative survival rates at 1, 5, and 10 years were 54%, 39%, and 29%, respectively. The prognosis was influenced by the risk grade and the number of variceal bleeds before entering the study and to a lesser extent by the etiology of the cirrhosis. Fifty-two per cent of the patients died during the 10-year period. Liver failure was the major cause of death. Complications were mostly of a minor nature but they became cumulative with time. Minor complications included mucosal slough and injection-site leak, although the latter had an associated mortality risk. Significant esophageal stenosis and esophageal rupture were rare. As a result of this study a more radical surgical policy is proposed for sclerotherapy failures. These are defined as patients in whom varices are difficult to eradicate or who continue to have major variceal bleeds. Such patients should be subjected to either a portosystemic shunt or a devascularization and transection procedure.

Full text

PDF
725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsoum M. S., Bolous F. I., El-Rooby A. A., Rizk-Allah M. A., Ibrahim A. S. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg. 1982 Feb;69(2):76–78. doi: 10.1002/bjs.1800690206. [DOI] [PubMed] [Google Scholar]
  2. Bornman P. C., Kahn D., Terblanche J., Worthley C., Spence R. A., Krige J. J. Rigid versus fiberoptic endoscopic injection sclerotherapy. A prospective randomized controlled trial in patients with bleeding esophageal varices. Ann Surg. 1988 Aug;208(2):175–178. doi: 10.1097/00000658-198808000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burroughs A. K., Jenkins W. J., Sherlock S., Dunk A., Walt R. P., Osuafor T. O., Mackie S., Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983 Dec 22;309(25):1539–1542. doi: 10.1056/NEJM198312223092502. [DOI] [PubMed] [Google Scholar]
  4. Cello J. P., Grendell J. H., Crass R. A., Weber T. E., Trunkey D. D. Endoscopic sclerotherapy versus portacaval shunt in patient with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med. 1987 Jan 1;316(1):11–15. doi: 10.1056/NEJM198701013160103. [DOI] [PubMed] [Google Scholar]
  5. Fleig W. E., Stange E. F., Hunecke R., Schönborn W., Hurler U., Rainer K., Gaus W., Ditschuneit H. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology. 1987 Mar-Apr;7(2):355–361. doi: 10.1002/hep.1840070224. [DOI] [PubMed] [Google Scholar]
  6. Johnston G. W., Rodgers H. W. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973 Oct;60(10):797–800. doi: 10.1002/bjs.1800601011. [DOI] [PubMed] [Google Scholar]
  7. Kahn D., Bornman P. C., Terblanche J. A 10-year prospective evaluation of balloon tube tamponade and emergency injection sclerotherapy for actively bleeding oesophageal varices. HPB Surg. 1989 Oct;1(3):207–219. doi: 10.1155/1989/98263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kahn D., Jones B., Bornman P. C., Terblanche J. Incidence and management of complications after injection sclerotherapy: a ten-year prospective evaluation. Surgery. 1989 Feb;105(2 Pt 1):160–165. [PubMed] [Google Scholar]
  9. Kahn D., Terblanche J., Kitano S., Bornman P. Injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Br J Surg. 1987 Jul;74(7):600–602. doi: 10.1002/bjs.1800740720. [DOI] [PubMed] [Google Scholar]
  10. Kitano S., Koyanagi N., Iso Y., Higashi H., Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology. 1987 Sep-Oct;7(5):810–815. doi: 10.1002/hep.1840070503. [DOI] [PubMed] [Google Scholar]
  11. Korula J., Balart L. A., Radvan G., Zweiban B. E., Larson A. W., Kao H. W., Yamada S. A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology. 1985 Jul-Aug;5(4):584–589. doi: 10.1002/hep.1840050410. [DOI] [PubMed] [Google Scholar]
  12. Larson A. W., Cohen H., Zweiban B., Chapman D., Gourdji M., Korula J., Weiner J. Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. JAMA. 1986 Jan 24;255(4):497–500. [PubMed] [Google Scholar]
  13. Lebrec D., Poynard T., Bernuau J., Bercoff E., Nouel O., Capron J. P., Poupon R., Bouvry M., Rueff B., Benhamou J. P. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology. 1984 May-Jun;4(3):355–358. doi: 10.1002/hep.1840040301. [DOI] [PubMed] [Google Scholar]
  14. McCormack T. T., Kennedy H. J., Salisbury J., Simms J. M., Triger D. R., Johnson A. G. Implications of a sclerotherapy program for the medical and surgical care of bleeding in portal hypertension. Surg Gynecol Obstet. 1985 Dec;161(6):557–562. [PubMed] [Google Scholar]
  15. Paquet K. J., Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology. 1985 Jul-Aug;5(4):580–583. doi: 10.1002/hep.1840050409. [DOI] [PubMed] [Google Scholar]
  16. Paquet K. J., Oberhammer E. Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy. 1978 Feb;10(1):7–12. doi: 10.1055/s-0028-1098252. [DOI] [PubMed] [Google Scholar]
  17. Rikkers L. F., Burnett D. A., Volentine G. D., Buchi K. N., Cormier R. A. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg. 1987 Sep;206(3):261–271. doi: 10.1097/00000658-198709000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spence R. A., Anderson J. R., Johnston G. W. Twenty-five years of injection sclerotherapy for bleeding varices. Br J Surg. 1985 Mar;72(3):195–198. doi: 10.1002/bjs.1800720315. [DOI] [PubMed] [Google Scholar]
  19. Söderlund C., Ihre T. Endoscopic sclerotherapy v. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment. Acta Chir Scand. 1985;151(5):449–456. [PubMed] [Google Scholar]
  20. Terblanche J., Bornman P. C., Jonker M. A., Kirsch R. E., Saunders S. J. Injection sclerotherapy of esophageal varices. Semin Liver Dis. 1982 Aug;2(3):233–241. doi: 10.1055/s-2008-1040711. [DOI] [PubMed] [Google Scholar]
  21. Terblanche J., Bornman P. C., Kahn D., Jonker M. A., Campbell J. A., Wright J., Kirsch R. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet. 1983 Dec 10;2(8363):1328–1332. doi: 10.1016/s0140-6736(83)91090-5. [DOI] [PubMed] [Google Scholar]
  22. Terblanche J., Northover J. M., Bornman P., Kahn D., Silber W., Barbezat G. O., Sellars S., Campbell J. A., Saunders S. J. A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet. 1979 Mar;148(3):323–333. [PubMed] [Google Scholar]
  23. Terblanche J. Sclerotherapy for prophylaxis of variceal bleeding. Lancet. 1986 Apr 26;1(8487):961–963. doi: 10.1016/s0140-6736(86)91056-1. [DOI] [PubMed] [Google Scholar]
  24. Terblanche J. The long-term management of patients after an oesophageal variceal bleed: the role of sclerotherapy. Br J Surg. 1985 Feb;72(2):88–90. doi: 10.1002/bjs.1800720204. [DOI] [PubMed] [Google Scholar]
  25. Terblanche J., Yakoob H. I., Bornman P. C., Stiegmann G. V., Bane R., Jonker M., Wright J., Kirsch R. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg. 1981 Oct;194(4):521–530. doi: 10.1097/00000658-198110000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Terés J., Bordas J. M., Bravo D., Visa J., Grande L., Garcia-Valdecasas J. C., Pera C., Rodés J. Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology. 1987 May-Jun;7(3):430–436. doi: 10.1002/hep.1840070303. [DOI] [PubMed] [Google Scholar]
  27. Warren W. D., Henderson J. M., Millikan W. J., Galambos J. T., Brooks W. S., Riepe S. P., Salam A. A., Kutner M. H. Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg. 1986 May;203(5):454–462. doi: 10.1097/00000658-198605000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Westaby D., Macdougall B. R., Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology. 1985 Sep-Oct;5(5):827–830. doi: 10.1002/hep.1840050520. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES